drugset / Trial / NCT04951726

Neostigmine Route for Acute Colonic Pseudo Obstruction

NCT04951726

Phase 4 Unknown 90 enrolled University of Southern California
RandomizedParallel-groupOpen-labelTreatment

Summary

Neostigmine is commonly used for medical treatment of acute colonic pseudo obstruction, however, the ideal route of administration has not been determined. Though IV push works rapidly, it is likely associated with the most side effects. This study will compare the efficacy and side effect profile of 2 potential routes of administration: IV push and subcutaneous.

Timeline

Start
2022-02-04
Primary completion
2025-08-01
Completion
2025-08-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 1 mg Intravenous
Subject Neostigmine Other / unclassified 2 mg Intravenous